210 related articles for article (PubMed ID: 25547133)
1. Outcomes of children exposed in utero to chemotherapy for breast cancer.
Murthy RK; Theriault RL; Barnett CM; Hodge S; Ramirez MM; Milbourne A; Rimes SA; Hortobagyi GN; Valero V; Litton JK
Breast Cancer Res; 2014 Dec; 16(6):500. PubMed ID: 25547133
[TBL] [Abstract][Full Text] [Related]
2. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.
Hahn KM; Johnson PH; Gordon N; Kuerer H; Middleton L; Ramirez M; Yang W; Perkins G; Hortobagyi GN; Theriault RL
Cancer; 2006 Sep; 107(6):1219-26. PubMed ID: 16894524
[TBL] [Abstract][Full Text] [Related]
3. In utero exposure to breast cancer treatment: a population-based perinatal outcome study.
Safi N; Anazodo A; Dickinson JE; Lui K; Wang AY; Li Z; Sullivan EA
Br J Cancer; 2019 Oct; 121(8):719-721. PubMed ID: 31488880
[TBL] [Abstract][Full Text] [Related]
4. Treatment of breast cancer during pregnancy: an observational study.
Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
[TBL] [Abstract][Full Text] [Related]
5. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
Cardonick E; Usmani A; Ghaffar S
Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
[TBL] [Abstract][Full Text] [Related]
6. Perinatal outcome in pregnant women with cancer: are there any effects of chemotherapy?
Garofalo S; Degennaro VA; Salvi S; De Carolis MP; Capelli G; Ferrazzani S; De Carolis S; Lanzone A
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27642062
[TBL] [Abstract][Full Text] [Related]
7. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls.
Cardonick EH; Gringlas MB; Hunter K; Greenspan J
Am J Obstet Gynecol; 2015 May; 212(5):658.e1-8. PubMed ID: 25434835
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group.
Martin M; Villar A; Sole-Calvo A; Gonzalez R; Massuti B; Lizon J; Camps C; Carrato A; Casado A; Candel MT; Albanell J; Aranda J; Munarriz B; Campbell J; Diaz-Rubio E;
Ann Oncol; 2003 Jun; 14(6):833-42. PubMed ID: 12796019
[TBL] [Abstract][Full Text] [Related]
9. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy.
Abdel-Hady el-S; Hemida RA; Gamal A; El-Zafarany M; Toson E; El-Bayoumi MA
Arch Gynecol Obstet; 2012 Aug; 286(2):283-6. PubMed ID: 22410958
[TBL] [Abstract][Full Text] [Related]
10. Children exposed to chemotherapy in utero.
Gwyn K
J Natl Cancer Inst Monogr; 2005; (34):69-71. PubMed ID: 15784828
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
Ring AE; Smith IE; Jones A; Shannon C; Galani E; Ellis PA
J Clin Oncol; 2005 Jun; 23(18):4192-7. PubMed ID: 15961766
[TBL] [Abstract][Full Text] [Related]
12. Sixteen years follow-up results of a randomized phase II trial of neoadjuvant fluorouracil, doxorubicin, and cyclophosphamide (FAC) compared with cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in stage III breast cancer: GOCS experience.
Leone JP; Leone J; Vallejo CT; Pérez JE; Romero AO; Machiavelli MR; Romero Acuña L; Domínguez ME; Langui M; Fasce HM; Leone BA; Ortiz E; Iturbe J; Zwenger AO
Breast Cancer Res Treat; 2014 Jan; 143(2):313-23. PubMed ID: 24327333
[TBL] [Abstract][Full Text] [Related]
13. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
Kerr JR
Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
[TBL] [Abstract][Full Text] [Related]
14. Management of breast cancer during pregnancy using a standardized protocol.
Berry DL; Theriault RL; Holmes FA; Parisi VM; Booser DJ; Singletary SE; Buzdar AU; Hortobagyi GN
J Clin Oncol; 1999 Mar; 17(3):855-61. PubMed ID: 10071276
[TBL] [Abstract][Full Text] [Related]
15. Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen.
Martín M; Lluch A; Seguí MA; Ruiz A; Ramos M; Adrover E; Rodríguez-Lescure A; Grosse R; Calvo L; Fernandez-Chacón C; Roset M; Antón A; Isla D; del Prado PM; Iglesias L; Zaluski J; Arcusa A; López-Vega JM; Muñoz M; Mel JR
Ann Oncol; 2006 Aug; 17(8):1205-12. PubMed ID: 16766587
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer during pregnancy: maternal and fetal outcomes.
Cardonick E; Dougherty R; Grana G; Gilmandyar D; Ghaffar S; Usmani A
Cancer J; 2010; 16(1):76-82. PubMed ID: 20164696
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy with taxanes in breast cancer during pregnancy: case report and review of the literature.
Potluri V; Lewis D; Burton GV
Clin Breast Cancer; 2006 Jun; 7(2):167-70. PubMed ID: 16800979
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC).
Boér K; Láng I; Juhos E; Pintér T; Szántó J
Pathol Oncol Res; 2003; 9(3):166-9. PubMed ID: 14530809
[TBL] [Abstract][Full Text] [Related]
19. Multimodal cancer chemotherapy during the first and second trimester of pregnancy: a case report.
Giannakopoulou C; Manoura A; Hatzidaki E; Korakaki E; Froudarakis G; Koumandakis E
Eur J Obstet Gynecol Reprod Biol; 2000 Jul; 91(1):95-7. PubMed ID: 10817888
[TBL] [Abstract][Full Text] [Related]
20. Combined chemotherapy and teratogenicity.
Paskulin GA; Gazzola Zen PR; de Camargo Pinto LL; Rosa R; Graziadio C
Birth Defects Res A Clin Mol Teratol; 2005 Sep; 73(9):634-7. PubMed ID: 16104005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
